1. Home
  2. AURA vs SEAT Comparison

AURA vs SEAT Comparison

Compare AURA & SEAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AURA
  • SEAT
  • Stock Information
  • Founded
  • AURA 2007
  • SEAT 2001
  • Country
  • AURA United States
  • SEAT United States
  • Employees
  • AURA N/A
  • SEAT N/A
  • Industry
  • AURA Biotechnology: Pharmaceutical Preparations
  • SEAT Industrial Machinery/Components
  • Sector
  • AURA Health Care
  • SEAT Industrials
  • Exchange
  • AURA Nasdaq
  • SEAT Nasdaq
  • Market Cap
  • AURA 370.1M
  • SEAT 366.2M
  • IPO Year
  • AURA 2021
  • SEAT N/A
  • Fundamental
  • Price
  • AURA $5.23
  • SEAT $1.79
  • Analyst Decision
  • AURA Strong Buy
  • SEAT Buy
  • Analyst Count
  • AURA 4
  • SEAT 11
  • Target Price
  • AURA $22.75
  • SEAT $4.49
  • AVG Volume (30 Days)
  • AURA 168.0K
  • SEAT 2.5M
  • Earning Date
  • AURA 05-20-2025
  • SEAT 05-06-2025
  • Dividend Yield
  • AURA N/A
  • SEAT N/A
  • EPS Growth
  • AURA N/A
  • SEAT N/A
  • EPS
  • AURA N/A
  • SEAT N/A
  • Revenue
  • AURA N/A
  • SEAT $748,757,000.00
  • Revenue This Year
  • AURA N/A
  • SEAT N/A
  • Revenue Next Year
  • AURA N/A
  • SEAT $5.90
  • P/E Ratio
  • AURA N/A
  • SEAT N/A
  • Revenue Growth
  • AURA N/A
  • SEAT 0.82
  • 52 Week Low
  • AURA $4.84
  • SEAT $1.66
  • 52 Week High
  • AURA $12.38
  • SEAT $5.90
  • Technical
  • Relative Strength Index (RSI)
  • AURA 42.97
  • SEAT 30.99
  • Support Level
  • AURA $4.94
  • SEAT $2.65
  • Resistance Level
  • AURA $6.29
  • SEAT $1.90
  • Average True Range (ATR)
  • AURA 0.44
  • SEAT 0.17
  • MACD
  • AURA 0.02
  • SEAT -0.08
  • Stochastic Oscillator
  • AURA 21.48
  • SEAT 9.63

About AURA Aura Biosciences Inc.

Aura Biosciences Inc is a clinical-stage biotechnology company developing precision immunotherapies to treat a range of solid tumors designed to preserve the function of organs afflicted with cancer. Its lead candidate bel-sar is in late-stage clinical development for the treatment of patients with primary choroidal melanoma, and other ocular oncology indications as well as in early-stage clinical development in bladder cancer. The Company views its operations and manages its business in one operating segment operating exclusively in the United States.

About SEAT Vivid Seats Inc.

Vivid Seats Inc is an online ticket marketplace for connecting fans to live events and artists. It is the official ticketing partner of brands in the entertainment industry providing tickets for sports, concerts, theatres, and comedy events in the United States, Canada and Japan. It operates in two segments namely marketplace and resale. Marketplace segment, act as an intermediary between ticket buyers, sellers, and partners through which company earn revenue from processing ticket sales for live events and facilitating the booking of hotel rooms and packages on websites and mobile applications. Resale segment provides internal research and development support for Skybox and supplements ongoing efforts to deliver software and tools. Majority of revenue is from Marketplace segment.

Share on Social Networks: